Amgen Inc

Ownership Transactions Reported by 26 Insiders

Symbol
AMGN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
One Amgen Center Drive, Thousand Oaks, CA

Insiders trading volume in the past year

Amgen Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert A. Bradway Chairman, CEO and President, Director $232M May 7, 2024
Esteban Santos EVP, Operations $33.4M May 7, 2024
Murdo Gordon EVP, Global Commercial Ops $30.2M May 7, 2024
David M. Reese EVP & Chief Technology Officer $25.5M May 7, 2024
Peter H. Griffith Evp & Cfo $17.4M May 7, 2024
Jonathan P. Graham EVP & Gen. Counsel & Secy. $16.5M May 7, 2024
James E. Bradner EVP, R&D, & Chief Sci. Officer $13.5M May 7, 2024
Lori A. Johnston Evp, Hr $11.2M Mar 1, 2022
Robert Eckert Director $7.12M May 31, 2024
Derek Miller SVP, Human Resources $6.17M May 7, 2024
Ronald D. Sugar Director $5.37M May 19, 2023
Tyler Jacks Director $4.81M May 31, 2024
Nancy A. Grygiel Svp & Cco $3.93M -$1.24M -23.9% Jul 31, 2024
Linda H. Louie VP, Finance & CAO $3.8M May 5, 2023
Charles M. Holley Director $3.79M Nov 4, 2024
Greg C. Garland Director $3.72M May 31, 2024
Rachna Khosla SVP, Business Development $3.7M Nov 5, 2024
Ellen Jamison Kullman Director $3.69M May 31, 2024
Matthew C. Busch VP, Finance & CAO $2.16M Nov 5, 2024
Wanda M. Austin Director $1.97M May 31, 2024
Brian Druker Director $1.94M May 31, 2024
R. Sanders Williams Director $1.7M May 19, 2023
Omar Ishrak Director $1.69M Nov 4, 2024
Michael V. Drake Director $1.18M Nov 4, 2024
Amy E. Miles Director $1.18M May 31, 2024
Mary E. Klotman Director $216K May 31, 2024

Recent Insider Transactions by Companies or Individuals for Amgen Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.